{"id":18229,"date":"2021-03-26T09:17:48","date_gmt":"2021-03-26T13:17:48","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=18229"},"modified":"2021-03-26T09:17:48","modified_gmt":"2021-03-26T13:17:48","slug":"seven-ipos-replenish-the-pipeline-seven-on-deck-before-easter-holiday","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/seven-ipos-replenish-the-pipeline-seven-on-deck-before-easter-holiday\/","title":{"rendered":"Seven IPOs Replenish the Pipeline; Seven on Deck before Easter Holiday"},"content":{"rendered":"

NEW FILINGS<\/strong><\/p>\n

Company: Neuropace Inc
\nSymbol: NPCE
\nDescription: They are a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Morgan Stanley, Wells Fargo, SVB Leerink
\nFiled: 3-24-21
\nListed Cash Raise: $75m<\/p>\n

Company: TuSimple Holdings Inc
\nSymbol: TSP
\nDescription: They are an autonomous technology company that is revolutionizing the estimated $4 trillion global truck freight market.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Citigroup, JP Morgan
\nFiled: 3-23-21
\nListed Cash Raise: $100m<\/p>\n

Company: Zymergen Inc.
\nSymbol: ZY
\nDescription: They partner with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank, Lazard
\nFiled: 3-23-21
\nListed Cash Raise: $100m<\/p>\n

Company: Recursion Pharmaceuticals, Inc..
\nSymbol: RXRX
\nDescription: They are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, JP Morgan, BofA Securities, SVB Leerink, Allen & Co.
\nCo-Manager(s): KeyBanc Capital
\nFiled: 3-22-21
\nListed Cash Raise: $100m<\/p>\n

Company: KnowBe4, Inc.
\nSymbol: KNBE
\nDescription: KnowBe4 has developed the leading security awareness platform enabling organizations to assess, monitor and minimize the ongoing cybersecurity threat of social engineering attacks.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, BofA Securities, KKR, Citigroup, UBS
\nCo-Manager(s): Baird, Canaccord Genuity, Cowen, Needham, Piper Sandler, Truist Securities
\nFiled: 3-19-21
\nListed Cash Raise: $100m<\/p>\n

Company: VectivBio Holding AG
\nSymbol: VECT
\nDescription: They are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. We are led by an experienced management team with a strong track record in the biotechnology and pharmaceutical industry.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, SVB Leerink, Credit Suisse
\nCo-Manager(s): LifeSci Capital
\nFiled: 3-19-21
\nListed Cash Raise: $100m<\/p>\n

Company: Reneo Pharmaceuticals, Inc.
\nSymbol: RPHM
\nDescription: Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP).
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, SVB Leerink, Piper Sandler
\nFiled: 3-19-21
\nListed Cash Raise: $100m<\/p>\n

TERMS ADDED<\/strong><\/p>\n

Company: Achilles Therapeutics plc
\nSymbol: ACHL
\nShares: 9.75 million ADSS
\nPrice Range: $17.00-$19.00
\nMarket Cap: $691m-$772m
\nTrade Date: Wednesday 3\/31
\nDescription: They are a clinical stage immuno-oncology biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumors.
\nUnderwriter(s): JP Morgan, BofA Securities, Piper Sandler
\nCo Manager(s): Chardan, Oppenheimer & Co., Kempen & Co
\nTerms Added: 3-25-21<\/p>\n

Company: Frontier Group Holdings
\nSymbol: FRNT
\nDescription: Frontier Airlines is an ultra low-cost carrier whose business strategy is focused on Low Fares Done Right\u00ae.
\nShares: 30 million
\nPrice Range: $19.00-$21.00
\nMarket Cap: $4.1b-$4.5b
\nTrade Date: Thursday, 4\/1
\nUnderwriter(s): Citigroup, Barclays, Deutsche Bank Securities, Morgan Stanley, Evercore ISI, BofA Securities, Goldman Sachs, JP Morgan, Nomura, UBS
\nCo-Manager(s): Cowen, Raymond James
\nTerms Added: 3-23-21<\/p>\n

Company: Compass, Inc.
\nSymbol: COMP
\nShares: 36 million
\nPrice Range: $23.00-$26.00
\nMarket Cap: $9.15b-$10.35b
\nTrade Date: Thursday, 4\/1
\nDescription: Compass provides an end-to-end platform that empowers our residential real estate agents to deliver exceptional service to seller and buyer clients.
\nUnderwriter(s): Goldman Sachs,Morgan Stanley, Barclays, Deutsche Bank, UBS Investment Bank
\nCo-Manager(s): Oppenheimer, Needham, Zelman Partners, Loop Capital, Academy Securities, Blaylock Van LLC, Ramirez & Co., Siebert Williams Shank
\nTerms Added: 3-23-21<\/p>\n

Company: Kaltura Inc
\nSymbol: KLTR
\nShares: 23.5 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $1.7b-$2.0b
\nTrade Date: Thursday 4\/1
\nDescription: Their Video Experience Cloud offers live, real-time, and on-demand video products including Video Portal, Town Halls, Video Messaging, Webinars, Virtual Events and Meetings.
\nUnderwriter(s): Goldman Sachs, BofA Securities, Wells Fargo, Deutsche Bank
\nCo-Manager(s): Canaccord Genuity, JMP Securities, KeyBanc Capital, Needham, Oppenheimer
\nTerms Added: 3-23-21<\/p>\n

Company: Intermedia Cloud Communications, Inc.
\nSymbol: INTM
\nShares: 12.2 million
\nPrice Range: $23.00-$26.00
\nMarket Cap: $1.33b-$1.5b
\nTrade Date: Thursday, 4\/1
\nDescription: They provide a leading, proprietary cloud-based communications and collaboration platform, purpose-built for our extensive and expanding network of more than 7,000 channel partners and used by a growing base of over 122,000 business customers as of December 31, 2020.
\nUnderwriter(s): Morgan Stanley, JP Morgan, Credit Suisse, Evercore ISI, Jefferies
\nCo-Manager(s): William Blair, KeyBanc Capital, TD Securities, Stephens, Loop Capital
\nTerms Added: 3-23-21<\/p>\n

Company: Coursera, Inc..
\nSymbol: COUR
\nDescription: They have built a global platform connecting learners, educators, and institutions, providing world-class educational content that is affordable, accessible, and relevant.
\nShares: 15.7 million
\nPrice Range: $30.00-$33.00
\nMarket Cap: 3.9b-$4.3b
\nTrade Date: Wednesday, 3\/31
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Citigroup, UBS Investment Bank
\nCo-Manager(s): KeyBanc Capital, Raymond James, Stifel, Truist Securities, William Blair, DA Davidson, Needham & Co., Loop Capital, Telsey Advisory Group
\nTerms Added: 3-22-21<\/p>\n

Company: Karooooo Ltd.
\nSymbol: KARO
\nShares: 4 million
\nPrice Range: $47.52-$47.52
\nMarket Cap: $966m-$966m
\nTrade Date: Wednesday 3\/31
\nDescription: Cartrack is a leading global provider of real-time mobility data analytics solutions for smart transportation
\nUnderwriter(s): Morgan Stanley, BofA Securities, William Blair
\nCo-Manager(s): Canaccord Genuity, Raymond James, Stifel
\nTerms Added: 3-22-21
\nNote: The ordinary shares of Cartrack Holdings Limited, our subsidiary, are listed on the securities exchange operated by JSE Limited (the \u201cJSE\u201d) under the symbol \u201cCTK\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-18229","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/18229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=18229"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/18229\/revisions"}],"predecessor-version":[{"id":18230,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/18229\/revisions\/18230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=18229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=18229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=18229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}